Long-term Host Immune Response Trajectories Among Hospitalized Patients With Sepsis
JAMA Network Open2019Vol. 2(8), pp. e198686–e198686
Citations Over TimeTop 1% of 2019 papers
Sachin Yende, John A. Kellum, Victor B. Talisa, Octavia M. Peck Palmer, Chung‐Chou H. Chang, Michael R. Filbin, Nathan I. Shapiro, Peter C. Hou, Arvind Venkat, Frank LoVecchio, Katrina Hawkins, Elliott D. Crouser, Anne B. Newman, Derek C. Angus
Abstract
In this study, persistent elevation of inflammation and immunosuppression biomarkers occurred in two-thirds of patients who survived a hospitalization for sepsis and was associated with worse long-term outcomes.
Related Papers
- → Current Use of Immunosuppression in Liver Transplantation(2023)3 cited
- → Immunosuppression after pediatric liver transplant: The parents’ perspective(2023)3 cited
- Individual immunosuppression regime in liver transplant recipients with high risk factors(2003)
- [The mechanism of immunosuppression in tumor-bearing mice--different susceptibility of various immune responses to immunosuppression and macrophage series as targets for immunosuppression (author's transl)].(1981)
- → General Principle of Immunosuppression(2013)